An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial-Reference-Cited by-同舟云学术

An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial

Published:2024-08 Issue:8 Volume:24 Page:829-844
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Pollock Katrina M,Borges Álvaro H,Cheeseman Hannah M,Rosenkrands Ida,Schmidt Kirstine L,Søndergaard Rie E,Day Suzanne,Evans Abbey,McFarlane Leon R,Joypooranachandran Jennifer,Amini Fahimah,Skallerup Per,Dohn Rebecca B,Jensen Charlotte G,Olsen Anja W,Bang Peter,Cole Tom,Schronce Joanna,Lemm Nana-Marie,Kristiansen Max P,Andersen Peter L,Dietrich Jes,Shattock Robin J,Follmann Frank

Publisher

Elsevier BV

Reference25 articles.

1. Chlamydia trachomatis Infections;Stephen,2020

2. Trachoma;Solomon;Nat Rev Dis Primers,2022

3. Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice;Olsen;Nat Commun,2024

4. Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial;Abraham;Lancet Infect Dis,2019

5. Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements;Agger;PLoS One,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral Vector-Based Chlamydia trachomatis Vaccines Encoding CTH522 Induce Distinct Immune Responses in C57BL/6J and HLA Transgenic Mice;Vaccines;2024-08-22

2. Immunological responses in a Chlamydia trachomatis vaccine trial;The Lancet Infectious Diseases;2024-08

3. Immunity to Sexually Transmitted Bacterial Infections of the Female Genital Tract: Toward Effective Vaccines;Vaccines;2024-08-01

4. Structural Assessment of Chlamydia trachomatis Major Outer Membrane Protein (MOMP)-Derived Vaccine Antigens and Immunological Profiling in Mice with Different Genetic Backgrounds;Vaccines;2024-07-18